Delivery Order SPE2DB22D2206-SPE2DB26FDT96
- Not listed
- The Defense Logistics Agency awarded a $12,819.24 delivery order to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100-strength capsules on September 17, 2025, with an ultimate completion date of September 18, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a pharmaceutical supply delivery under the company's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of 36,000 units of Creon DR 100s capsules, valued at $6,150.38. This competitively awarded, firm fixed-price delivery order is set to be completed by July 30, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal...
- The Defense Logistics Agency awarded a $7,093.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for 36,000 units of Creon DR 100-strength capsules, with an ultimate completion date of August 29, 2025. This competitively awarded, non-set-aside contract represents a single delivery order for pharmaceutical supplies to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of 36,000 unit capsules of Creon DR 100s with a ceiling value of $58,274.04. This firm fixed-price delivery order is scheduled for completion by September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation and represents a continuation of the...
- The Defense Logistics Agency awarded a $8,144.34 firm fixed price delivery order to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100s capsules, with an ultimate completion date of September 4, 2025. This non-set-aside contract was awarded competitively and represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical support vehicle that runs through December 2026. The product will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of 36,000 units of Creon DR 100 strength capsules, valued at $9,284.69. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by October 28, 2025, with performance to be fulfilled from the vendor's Conshohocken, Pennsylvania location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $42,783.63 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of 36,000 units of Creon DR 100s capsules. The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award, and is scheduled for completion by August 20, 2025. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Creon DR 24,000 unit capsules (100 count) with a ceiling value of $2,262.52 and an ultimate completion date of August 11, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $14,406.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for 36,000 unit capsules of Creon (pancrelipase) in 100-count packages, with completion scheduled for September 10, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award is non-set-aside and was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Creon (pancrelipase) 36,000-unit capsules in 100-count bottles, with a ceiling value of $11,364.41 and a firm fixed price structure. This is a non-set-aside competitive award with an ultimate completion date of September 29, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB26FDT96Delivery Order
The Defense Logistics Agency awarded a $6,737.86 delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of 36,000 units of Creon DR 100 strength capsules, with an ultimate completion date of October 28, 2025. This firm fixed price delivery order, which is not set-aside, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement under the company's existing federal supply arrangements with the Defense Logistics Agency's medical supply chain operations. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical prime vendor agreement running through December 2026. As a major pharmaceutical distributor, AmerisourceBergen has demonstrated consistent capability in fulfilling federal medical procurement requirements through competitive awards and serves as a critical vendor for military and veteran healthcare systems. The Creon DR supply supports the company's comprehensive role in delivering specialized medications and medical commodities across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 10/27/25 |